Trials / Completed
CompletedNCT05449587
Long-Term Effectiveness of the Motiva Implants® Round and Round Ergonomix
Study of the Long-Term Effectiveness of the Motiva Implants® Round and Round Ergonomix in Primary and Revision Breast Augmentation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 111 (actual)
- Sponsor
- Motiva USA LLC · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
Post-marketing surveillance study to demonstrate the silent rupture rate and satisfaction of patients who underwent a primary and revision breast augmentation surgery with Motiva Implants®, 3 to 10 years before enrollment.
Detailed description
Single-arm, multicenter study with a minimum of 160 subjects who underwent Breast Implant surgery from 3-10 years postoperatively. Following IRB / EC approval - and if applicable Competent Authority approval - Magnetic Resonance Imaging (MRI) and Patient-Reported Outcome (PRO) with the validated BREAST-Q will be collected at a single time point for all enrolled subjects. MRI data will be used for the analysis of silent rupture, and BREAST-Q Postoperative Augmentation module scales to record patients for satisfaction. Two styles of Motiva Implants® will be used for this study: * Motiva Implants® Silicone Gel-Filled Breast Implants, SmoothSilk® Round (referred to as "Motiva Implants® Round ProgressiveGel® Plus", or "Round") * Motiva Implants® Silicone Gel-Filled Breast Implants, SmoothSilk® Round Ergonomix® (referred to as "Motiva Implants® Ergonomix® Round ProgressiveGel® Ultima®", or "Round Ergonomix"). Henceforth, these devices will generally be referenced as "Motiva Implants®."
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | MRI and PRO | MRI as a standard of care for the analysis of silent rupture. BREAST-Q Postoperative Augmentation module scales to record patients for satisfaction: Satisfaction with breasts; Satisfaction with outcome; Psychosocial well-being; Physical well-being |
Timeline
- Start date
- 2022-11-22
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2022-07-08
- Last updated
- 2024-10-31
Locations
2 sites across 1 country: Costa Rica
Source: ClinicalTrials.gov record NCT05449587. Inclusion in this directory is not an endorsement.